Skip to main content

Lorenzo Piemonte

Lorenzo Piemonti, MD, born in Carate Brianza, graduated with Summa cum Laude at the University of Milan in 1994, and specialized with Summa Cum Laude in Endocrinology and Metabolic Diseases  and in Micro and Experimental surgery at the University of Milan in 2000 and 2004, respectively. At the San Raffaele Scientific Institute (Milan, Italy) he serves as Director of Diabetes Research Institute, Director of Human Islet Transplantation Program. He also serves as Chief of the Beta Cell Biology Unit (Diabetes Research Institute), and Director of Human Islet Processing Facility, and coordinator of European Consortium for Islet Transplantation that has been providing Human beta Cell Products for research and clinical applications at OSR, in Italy and across state barriers in Europe since 2000 (See European Consortium for Islet Transplantation). He also serve as Professor in Endocrinology at University “Vita Salute San Raffaele” of Milan and as Honorary Visiting Professor at Vrije Universiteit of Brussel. His area of expertise is mainly focused on diabetes and pancreatology. In particular he has large experience about diabetes and pancreatic cancer. He has in the past studied the role of innate immunity in islet cell biology (especially in the human model of islet transplantation in type 1 diabetes recipient) and in pancreatic cancer biology (especially the role of chemokines and chemokine receptor system in inducing leukocytes infiltration). In addition, his research interests include beta cell replacement, immune tolerance induction strategies, dendritic cell biology, stem cells. He currently serves as section Editor of Cell Transplantation-the Regenerative Medicine Journal and of Current Diabetes Reports, as editorial board of Acta Dibetologia, as Councilor of the International Pancreas and Islet Transplantation Association (IPITA) of The Transplantation Society  (TTS) and as member of the European Pancreas and Islet Transplantation Association (EPITA) committee of European Society for Organ Transplantation (ESOT).

 Lorenzo Piemonti authored a total of 158 original articles published in peer-reviewed journals surveyed in PubMed. h-index (06/07/2017): 38 Web of Science; 41 Scopus; 47 Google Scholar. Considering the period 2001-2017 Lorenzo Piemonti authored a total of 135 original articles published in peer-reviewed journals for an impact factor of 779,673 (mean impact factor: 5.775)